Coexistence of sickle cell disease and systemic lupus erythematosus is associated with quantitative and qualitative impairments in circulating regulatory B cells

Mohamed Rachid Boulassel*, Amal Al-Naamani, Abeer Al-Zubaidi, Zahra Al-Qarni, Hammad Khan, Amar Oukil, Amira Al-Badi, Juma Al-Kaabi, Jalila Al-Shekaili, Sulaiman Al-Hashmi, Fahad Zadjali, Rizwan Nabi Qureshi, Vinodh Panjwani, Salam Al-Kindi

*المؤلف المقابل لهذا العمل

نتاج البحث: المساهمة في مجلةمراجعة النظراء

ملخص

The incidence of connective tissue diseases such as systemic lupus erythematous (SLE), in adult patients with sickle cell disease (SCD), appears to be increasing. The exact causes underlying this increased risk are still unknown, but a link with B regulatory (Breg) cells is possible as these cells suppress inflammatory responses, and maintain tolerance. Quantitative and qualitative analyses of circulating Breg cells were performed in a cohort of SCD patients with SLE, and their levels were correlated with key soluble mediators promoting autoreactive B cells. We demonstrated that levels of Breg cells were significantly decreased in SCD patients with SLE compared to patients with SCD only or healthy controls. Functional analysis of Breg cells from SCD patients with SLE revealed impairments in IL-10 production that correlated with lower levels of STAT3 phosphorylation, without abnormal expression of IL-10 receptor on Breg cells. On the other hand, BAFF levels were substantially elevated in SCD patients with SLE, but not significantly associated with Breg cell levels. Collectively, these results indicated numerical and functional deficits of Breg cells in SCD patients with SLE and their capacity to maintain tolerance and control inflammation is imbalanced, which leads to the development of autoimmune responses.

اللغة الأصليةEnglish
دوريةHuman Immunology
المعرِّفات الرقمية للأشياء
حالة النشرAccepted/In press - 2022

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2723???
  • ???subjectarea.asjc.2400.2403???

قم بذكر هذا